Pfizer Sponsored Satellite Session
Sunday, January 25, 2009 - 13:00 - 14:30
Improving the Outcomes of Psychiatry Related Metabolic Conditions
Introduction
Hans-Jürgen Möller, Germany
Case study 1 - progress review of a schizophrenic patient with cardiovascular disease
Marc De Hert, Belgium
Managing metabolic health in psychiatry - The Diabetologist's perspective
Jacqueline Dekker, The Netherlands
Preventing cardiovascular disease in psychiatric patients - The Cardiologist's perspective
John Camm, UK
Cardiovascular disease in severe mental illness - role of psychiatrists in effective risk management
John Newcomer, USA
Case study 2 - the dilemma of switching antipsychotics for improved cardiovascular outcomes
Marc De Hert, Belgium
Conclusion
Hans-Jürgen Möller, Germany
Bristol Myers Squibb and Otsuka Sponsored Satellite Session
Monday, January 26, 2009 - 13:00 - 14:30
A road map to sustainable treatment plans: integrating patient’s perspective, pharmacology, and clinical research evidence
Chairperson: Wolfgang Fleischhacker, Austria
The reality of taking antipsychotic medication
Köksal Alptekin, Turkey
Introducing the pharmacology behind treatments to understand treatment challenges
David Nutt, UK
Clinical research evidence for the use of antipsychotics
Eduard Vieta, Spain